scispace - formally typeset
S

Soma Guhathakurta

Researcher at Indian Institute of Technology Madras

Publications -  46
Citations -  539

Soma Guhathakurta is an academic researcher from Indian Institute of Technology Madras. The author has contributed to research in topics: Decellularization & Mesenchymal stem cell. The author has an hindex of 12, co-authored 46 publications receiving 477 citations. Previous affiliations of Soma Guhathakurta include Wellington Management Company & National Heart Foundation of Australia.

Papers
More filters
Journal Article

Cor triatriatum in adults: three new cases and a brief review.

TL;DR: The cases of 3 cases of cor triatriatum that were diagnosed late, in the 4th and 5th decades of life, and a review of this rare congenital cardiac anomaly are presented.
Journal ArticleDOI

Trans-differentiation of human mesenchymal stem cells generates functional hepatospheres on poly(L-lactic acid)-co-poly(ε-caprolactone)/collagen nanofibrous scaffolds

TL;DR: PLACL/collagen nanofibrous scaffolds are potentially biomimetic and upon sequential induction with hepatogenic growth factors/cytokines, it augments trans-differentiation of hMSCs towards functional hepatosphere formation.
Journal Article

Surgical treatment of right atrial myxoma.

TL;DR: A 51-year-old man with a large right atrial myxoma underwent emergency surgical resection and was fitted with a single cannula in the superior vena cava until fibrillation, and then a cannula was inserted into the inferior venaCava.
Journal ArticleDOI

Biomimetic acellular detoxified glutaraldehyde cross-linked bovine pericardium for tissue engineering

TL;DR: Lyophilized acellular detoxified GLUT cross-linked bovine pericardium, employed in this study as an alternative to conventional GLUTCross- linked bovines, might provide longer durability and better biocompatibility, and reduce calcification.
Journal ArticleDOI

A Patient-Inspired Ex Vivo Liver Tissue Engineering Approach with Autologous Mesenchymal Stem Cells and Hepatogenic Serum.

TL;DR: The fibrous mesh‐hepatocyte construct developed in this study using natural growth factors and BMSCs of same individual is promising for future therapeutic applications in treating damaged livers.